TABLE 2.

Association between CD14 C-159T genotype and categorized number of AOM episodes according to age

GenotypeNo. (%) of subjects with the indicated no. of AOM episodesa
Total cohortParticipants aged
12 to 24 mo>24 mo
2-3 Episodes≥4 Episodes2-3 Episodes≥4 Episodes2-3 Episodes≥4 Episodes
CD14 CC26 (31)57 (69)6 (21)22 (79)20 (36)35 (64)
CD14 CT50 (34)99 (66)12 (23)40 (77)38 (39)59 (61)
CD14 TT32 (47)36 (53)17 (59)12 (41)15 (38)24 (62)
  • a Retrospectively obtained data from the year before study entry. P values for the comparison of numbers of individuals with no recurrence of AOM with numbers of individuals with ≥1 recurring AOM episode according to the three genotype groups by using chi-square analyses are 0.5 for the total cohort, 0.04 for participants 12 to 24 months of age, and 0.5 for participants >24 months of age. P values for the comparison of numbers of individuals with no recurrence of AOM with numbers of individuals with ≥1 recurring AOM episode according to the homozygous CC and TT genotypes by using chi-square analyses are 0.3 for the total cohort, 0.01 for participants 12 to 24 months of age, and 0.5 for participants >24 months of age.